CLINICAL_TRIALS
trial_result
· 2018-11-28
Clinical Trial Update: Alzheimer Disease Proof of Concept Study With BI 409306 Versus Placebo [Phase 2]
Summary
Phase 2 proof-of-concept study comparing BI 409306 to placebo in Alzheimer disease completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Alzheimer Disease | Phase 2 | Status: COMPLETED | Results posted: 2018-11-28